logo
Breyers Ice Creams Recalled After Flavor Containing Life-Threatening Allergen Was Packaged as Another Flavor

Breyers Ice Creams Recalled After Flavor Containing Life-Threatening Allergen Was Packaged as Another Flavor

Yahoo12-06-2025
6,668 cases of Breyers Chocolate Truffle Ice Cream across the United States have been recalled by Unilever Manufacturing
The affected ice cream cartons actually contain Rocky Road Ice Cream, which contains almonds, a potentially "life-threatening" allergen
The U.S. Food and Drug Administration announced the recall on June 10Over 6,600 cases of Breyers Ice Cream have been recalled amid concerns that the product is mislabeled and contains a "life-threatening" allergen.
The U.S. Food and Drug Administration confirmed that 6,668 cases of Breyers Chocolate Truffle Ice Cream were voluntarily recalled by Unilever Manufacturing on June 2 in a Tuesday, June 10 statement.
The cause for the recall was determined to be "undeclared allergens and mislabeled product."
"Rocky Road Ice was packaged with Chocolate Truffle Ice Cream labeled tub and a Rocky Road Ice Cream lid. Tub said 'may contain tree nuts' the lid said it did contain almonds," the FDA clarified about the recall.
is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more!
The FDA declared this a Class II recall, which is defined as "a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."
A representative for Breyers commented on the recall in a statement shared with PEOPLE, saying, "Unilever in the U.S. is voluntarily recalling one lot of Breyers Chocolate Truffle 1.5 quart tubs after some were found to contain Rocky Road ice cream, which includes almonds not listed on the label."
The statement continued: "People with an almond allergy should not consume the product due to risk of serious or life-threatening allergic reaction. The safety and quality of our products is our top priority. For more information, consumers can visit www.breyers.com or call 1-800-931-2826."
It is unclear where exactly the cases of ice cream were distributed across the United States. The FDA reported the distribution as targeting "distribution centers and retail locations across the U.S."
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer​​, from celebrity news to compelling human interest stories.
Rocky Road is a flavor of ice cream that contains almonds. Although almonds are considered tree nuts, the label for Breyers Chocolate Truffle Ice Cream only says that the product "may contain tree nuts."
The Breyers recall comes a few weeks after nearly 18,000 containers of Wells Dairy ice cream and frozen yogurt were recalled due to contamination with hard plastics.
Wells Enterprises, which produces Wells Dairy products, was responsible for the recall, which targeted 22 different flavors of frozen desserts.
Read the original article on People
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Is EnVVeno Medical Stock (NVNO) Down 70% Today?
Why Is EnVVeno Medical Stock (NVNO) Down 70% Today?

Business Insider

time3 hours ago

  • Business Insider

Why Is EnVVeno Medical Stock (NVNO) Down 70% Today?

EnVVeno Medical (NVNO) stock took a beating after the medical device company's VenoValve surgical replacement venous valve for severe deep chronic venous insufficiency was rejected by the U.S. Food and Drug Administration (FDA). The FDA sent a non-approvable letter to EnVVeno Medical, stating it couldn't approve the Premarket Approval application for the product in its current form. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to EnVVeno Medical, the FDA wouldn't approve the medical device because 'the favorable revised Venous Clinical Severity Score (rVCSS) data generated by the study to show clinical improvement, together with the improvements in pain scores and venous specific quality of life indicators was not sufficient on its own to determine favorability of the benefit risk profile for the VenoValve.' EnVVeno Medical noted its disappointment with the FDA's decision and is weighing options, including a potential resubmission or appeal. The company also said that it will take into account what it has learned from this letter in its development of enVVe a non-surgical replacement venous valve that it plans to submit an IDE application for. EnVVeno Medical Stock Movement Today EnVVeno Medical stock was down 71.84% in pre-market trading, following a 16.12% drop yesterday. The shares were still up 38.74% year-to-date but were down 20.94% over the past 12 months. Today's news came with heavy trading, as some 3.6 million shares changed hands, compared to a three-month daily average of about 148,000 units. Is EnVVeno Medical Stock a Buy, Sell, or Hold? Turning to Wall Street, coverage of EnVVeno Medical is thin. Fortunately, TipRanks' AI analyst Spark has it covered. Spark rates NVNO stock a Neutral (58) with no price target. It cites 'robust technical performance, which is somewhat overshadowed by challenging financial metrics' as reasons for this stance.

Argenx treatment of idiopathic inflammatory myopathy granted orphan designation
Argenx treatment of idiopathic inflammatory myopathy granted orphan designation

Business Insider

time7 hours ago

  • Business Insider

Argenx treatment of idiopathic inflammatory myopathy granted orphan designation

Argenx (ARGX)' treatment of idiopathic inflammatory myopathy was granted FDA orphan designation, according to a post to the agency's site. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store